Menu

ADARx Pharmaceuticals, Inc. ADRX

Full chart Compare
Set alert

Price alert · ADRX

All alert types
14.98 USD +1.68 (+12.63%)

Nov 12, 2026, 3:46 PM EST

14.98 Day range 15.05
12.50 52-week range 23.21
YTD
-22.58%
1 year
-22.58%

ADRX revenue history

Revenue is income from the company’s ordinary business activities.

3,449,000 USD

FY 2025 · Period ended

Coverage: incomplete. Values in USD; not inflation adjusted.

Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.

FY 1995: 50,633,000USDFY 1996: 86,771,000USDFY 1997: 149,698,000USDFY 1998: 247,057,000USDFY 1999: 475,990,000USDFY 2000: 519,960,000USDFY 2001: 749,041,000USDFY 2002: 770,980,000USDFY 2003: 1,046,338,000USDFY 2004: 1,145,824,000USDFY 2005: 1,042,025,000USDFY 2024: 0USDFY 2025: 3,449,000USD

Scroll the table to see all values →

Revenue · annual · USD
Fiscal periodPeriod endRevenueYoY changeYoY %
FY 20252025-12-313,449,0003,449,000Not meaningful
FY 20242024-12-310Not availableNot available
FY 20052005-12-311,042,025,000-103,799,000-9.06%
FY 20042004-12-311,145,824,00099,486,0009.51%
FY 20032003-12-311,046,338,000275,358,00035.72%
FY 20022002-12-31770,980,00021,939,0002.93%
FY 20012001-12-31749,041,000229,081,00044.06%
FY 20002000-12-31519,960,00043,970,0009.24%
FY 19991999-12-31475,990,000228,933,00092.66%
FY 19981998-12-31247,057,00097,359,00065.04%
FY 19971997-12-31149,698,00062,927,00072.52%
FY 19961996-12-3186,771,00036,138,00071.37%
FY 19951995-12-3150,633,000Not availableNot available

Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.

Company-reported financial statements. Retrieved 2026-09-29T06:00:47.000Z. Retrieval time is not a report date.

Open full statements

Use Add to watchlist above to save this stock.